Product information
From Health Canada
No match found
No other product was found from this company.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2023-06-11
Product name:
NOREPINEPHRINE BITARTRATE INJECTION
Description:
SINGLE USE
DIN:
02538857
Product Monograph/Veterinary Labelling:
Date:
2023-06-07
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
THE J. MOLNER COMPANY INC.
21 Parr Boulevard, Unit 12
Caledon
Ontario
Canada
L7E 4G3
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
12:12.12
Anatomical Therapeutic Chemical (ATC): See footnote 4
C01CA03 NOREPINEPHRINE
Active ingredient group (AIG) number:See footnote5
0131301001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) | 1 MG / ML |